Effect of Individualized Homoeopathic Treatment In Influenza Like Illness- A multicentric, Single Blind, Randomized, Placebo Controlled Study.

Central Council for Research in Homoeopathy New Delhi0 个研究点目标入组 432 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Patients meet all of the following criteria shall be eligible for study participation:
•Patients of either sex, age group 12-60 years, presenting to study physician within 36hrs of onset of symptoms.
•Patients presenting with signs/symptoms of influenza like illnesses: Abrupt onset of fever (>=100.4Â°F or 38oC body temp.) with at least one respiratory symptom ï??cough, sore throat, or nasal symptom (discharge, obstruction)ï?? and at least one constitutional symptom (headache, malaise, myalgia, sweats or chills, or fatigue).

•Patients meeting any of the following criteria shall be excluded:
•Who have received other medication (anti-viral) within the 36 hours before entry into the study.
•Patients who had immunization against influenza or influenza like illnessess for that season.
•Inability to comply with the study protocol, including psychiatric diseases.
•Immune compromised or with other clinically active illness including cardiac or pulmonary diseases, hemoglobinopathies, renal dysfunction.
•Pregnant women.
•Lactating mother.
•History of drug or alcohol abuse.

发起方

Central Council for Research in Homoeopathy New Delhi